updated Sun. August 25, 2024
-
The Ledger Gazette
March 1, 2018
Denali Therapeutics (NASDAQ: DNLI) and Recro Pharma (NASDAQ:REPH) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, profitability, earnings, analyst recommendationsÃâà...
www.oncnursingnews.com/
February 27, 2018
Patients have found it helpful for sleep, anxiety, pain, and neuropathies. In a career where I have to give life-prolonging but toxic substances, I feel very thankful that I opened my mind and heart to this gentle, supplemental, non-invasive treatment. Many Eastern medical techniques have been around forÃâà...
Charcot-Marie-Tooth News
February 12, 2018
HDAC6, a key enzyme in the acetylation process, is a relevant clinical target in Alzheimer's and ALS, and has also been related to Charcot-Marie-Tooth. Mutations in enzymes known as aaRS, which are involved in protein production, have been shown in CMT disease and related peripheral neuropathies.
News-Medical.net
February 8, 2018
Inhibiting HDAC6 improves the structural stability of cells and protects against neuronal damage. Leuven research uncovered that targeting this mechanism could be a promising therapeutic approach for peripheral neuropathies, whether due to Charcot-Marie-Tooth disease (CMT) or as a side effect ofÃâà...
Science Daily
February 7, 2018
The guide can also direct translational research in peripheral neuropathies by observing how components may be disrupted or altered during disease or injury, and help develop better treatments for chronic pain. Ubogu's study started from normal frozen human sural nerves preserved in the Shin J. OhÃâà...
The Ledger Gazette
December 31, 1999
According to Zacks, “Neurometrix is a medical device company establishing a new standard of care through the design, development and sale of proprietary products used to diagnose neuropathies. Neuropathies are diseases of the peripheral nerves and parts of the spine that frequently are caused by orÃâà...
The Financial
December 31, 1999
Familial Amyloid Neuropathies Market Pipeline Review, H2 2017, latest report provides report provides a snapshot of the global therapeutic landscape of Familial Amyloid Neuropathies, Key players involved with pipeline review and targeted therapeutics covering drugs profile of Familial AmyloidÃâà...
|
news and opinion
|